298 related articles for article (PubMed ID: 26210200)
21. Outcome analysis of high-dose chemotherapy and autologous stem cell transplantation in adolescent and young adults with relapsed or refractory Hodgkin lymphoma.
Akhtar S; Rauf SM; Elhassan TA; Maghfoor I
Ann Hematol; 2016 Sep; 95(9):1521-35. PubMed ID: 27376363
[TBL] [Abstract][Full Text] [Related]
22. A comparison of clinical trial enrollment between adolescent and young adult (AYA) oncology patients treated at affiliated adult and pediatric oncology centers.
Downs-Canner S; Shaw PH
J Pediatr Hematol Oncol; 2009 Dec; 31(12):927-9. PubMed ID: 19855302
[TBL] [Abstract][Full Text] [Related]
23. Overcoming psychosocial and developmental barriers to blood and marrow transplantation (BMT) in an adolescent/young adult (AYA) transgender patient with chronic myelogenous leukemia.
Khazal S; Abdel-Azim H; Kapoor N; Mahadeo KM
Pediatr Hematol Oncol; 2014 Nov; 31(8):765-7. PubMed ID: 24854505
[TBL] [Abstract][Full Text] [Related]
24. Challenges in the recruitment of adolescents and young adults to cancer clinical trials.
Burke ME; Albritton K; Marina N
Cancer; 2007 Dec; 110(11):2385-93. PubMed ID: 17918260
[TBL] [Abstract][Full Text] [Related]
25. A national approach to improving adolescent and young adult (AYA) oncology psychosocial care: the development of AYA-specific psychosocial assessment and care tools.
Palmer S; Patterson P; Thompson K
Palliat Support Care; 2014 Jun; 12(3):183-8. PubMed ID: 23659778
[TBL] [Abstract][Full Text] [Related]
26. Spirituality and Spiritual Care of Adolescents and Young Adults with Cancer.
Taylor EJ; Petersen C; Oyedele O; Haase J
Semin Oncol Nurs; 2015 Aug; 31(3):227-41. PubMed ID: 26210201
[TBL] [Abstract][Full Text] [Related]
27. Gender differences in doxorubicin pharmacology for subjects with chemosensitive cancers of young adulthood.
Liu Z; Martin J; Orme L; Seddon B; Desai J; Nicholls W; Thomson D; Porter D; McCowage G; Underhill C; Cranswick N; Michael M; Zacharin M; Herschtal A; Sivasuthan J; Thomas DM
Cancer Chemother Pharmacol; 2018 Nov; 82(5):887-898. PubMed ID: 30206658
[TBL] [Abstract][Full Text] [Related]
28. Increased risk of second malignant neoplasms in adolescents and young adults with cancer.
Lee JS; DuBois SG; Coccia PF; Bleyer A; Olin RL; Goldsby RE
Cancer; 2016 Jan; 122(1):116-23. PubMed ID: 26441212
[TBL] [Abstract][Full Text] [Related]
29. Collaboration and Networking.
Husson O; Manten-Horst E; van der Graaf WT
Prog Tumor Res; 2016; 43():50-63. PubMed ID: 27595356
[TBL] [Abstract][Full Text] [Related]
30. Acute lymphoblastic leukemia in young adults: which treatment?
McNeer JL; Raetz EA
Curr Opin Oncol; 2012 Sep; 24(5):487-94. PubMed ID: 22691923
[TBL] [Abstract][Full Text] [Related]
31. Study Protocol to Evaluate Influences of Stress and Inflammation on Mucositis in Adolescents and Young Adults With Cancer.
Thornton CP; Kozachik S; Ruble K
Nurs Res; 2022 Sep-Oct 01; 71(5):404-410. PubMed ID: 35446269
[TBL] [Abstract][Full Text] [Related]
32. Children's Oncology Group 2023 blueprint for research: Adolescent and young adult oncology.
Roth ME; Grimes AC; Reed DR; Weiss AR; Mittal N; Parsons SK; Freyer DR;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30564. PubMed ID: 37439574
[TBL] [Abstract][Full Text] [Related]
33. High-dose ifosfamide/carboplatin/etoposide: maximum tolerable doses, toxicities, and hematopoietic recovery after autologous stem cell reinfusion.
Fields KK; Elfenbein GJ; Perkins JB; Janssen WE; Ballester OF; Hiemenz JW; Zorsky PE; Kronish LE; Foody MC
Semin Oncol; 1994 Oct; 21(5 Suppl 12):86-92. PubMed ID: 7527592
[TBL] [Abstract][Full Text] [Related]
34. Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis.
Cha S; Lee J; Shin JY; Kim JY; Sim SH; Keam B; Kim TM; Kim DW; Heo DS; Lee SH; Kim JI
BMC Cancer; 2016 Feb; 16():170. PubMed ID: 26925973
[TBL] [Abstract][Full Text] [Related]
35. Closing the gap: Novel therapies in treating acute lymphoblastic leukemia in adolescents and young adults.
Friend BD; Schiller GJ
Blood Rev; 2018 Mar; 32(2):122-129. PubMed ID: 28969872
[TBL] [Abstract][Full Text] [Related]
36. Adolescent and young adult cancer survival.
Lewis DR; Seibel NL; Smith AW; Stedman MR
J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):228-35. PubMed ID: 25417236
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and Intensity of Pain and Other Physical and Psychological Symptoms in Adolescents and Young Adults Diagnosed with Cancer on Referral to a Palliative Care Service.
Hughes RE; Holland LR; Zanino D; Link E; Michael N; Thompson KE
J Adolesc Young Adult Oncol; 2015 Jun; 4(2):70-5. PubMed ID: 26812554
[TBL] [Abstract][Full Text] [Related]
38. Active therapy and models of care for adolescents and young adults with cancer.
Ramphal R; Meyer R; Schacter B; Rogers P; Pinkerton R
Cancer; 2011 May; 117(10 Suppl):2316-22. PubMed ID: 21523752
[TBL] [Abstract][Full Text] [Related]
39. Acute myeloid leukemia in adolescents and young adults: challenging aspects.
Ofran Y; Rowe JM
Acta Haematol; 2014; 132(3-4):292-7. PubMed ID: 25228554
[TBL] [Abstract][Full Text] [Related]
40. The challenging aspects of managing adolescents and young adults with Hodgkin's lymphoma.
Jachimowicz RD; Engert A
Acta Haematol; 2014; 132(3-4):274-8. PubMed ID: 25228552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
